 SAN DIEGO, May 17, 2021 PRNewswire -- Evofem Biosciences, Inc. NASDAQ: EVFM today announced the pricing of its previously announced underwritten public offering of 50,000,000 shares of its common stock and accompanying short-term warrants to purchase up to an aggregate of 50,000,000 shares of common stock. Each share of common stock is being sold together with one short-term warrant to purchase one share of common stock at a combined public offering price of 1.00 per share of common stock and accompanying common warrant, less underwriting discounts and commissions. 